Neuroscience

Firefly Neuroscience Accepted into NVIDIA Connect Program

Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform          For…

10 months ago

Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new…

10 months ago

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Landmark single-cell dataset of one billion cells will be used to train new AI models to advance researchers' understanding of…

11 months ago

Vivistim Paired VNS Therapy Outcomes & Success at Comprehensive Stroke Centers Highlighted at ISC 2025

Dr. Ronald Benitez to present Vivistim safety and outcomes data for the largest cohort of ischemic stroke survivors AUSTIN, Texas…

11 months ago

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE…

11 months ago

Zafrens Expands Investor Syndicate to Scale Revolutionary Drug Discovery Platform

SAN DIEGO, Feb. 4, 2025 /PRNewswire/ -- Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series…

11 months ago

MedRhythms Hires Joel Behnke as Chief Commercial Officer; Announces New Publications in Support of InTandem®

PORTLAND, Maine, Feb. 4, 2025 /PRNewswire/ -- MedRhythms, Inc. today announced that Joel Behnke has been hired as Chief Commercial…

11 months ago

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride) for Parkinson’s Disease

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced…

11 months ago

Telehealth Market & Telemedicine Market to Hit USD 180.86 Billion by 2030 with 11.5% CAGR | MarketsandMarkets™

DELRAY BEACH, Fla., Feb. 3, 2025 /PRNewswire/ -- The Telehealth Market & Telemedicine market valued at US$ 83.62 Billion in 2023, is…

11 months ago

Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson’s Trial

Jupiter, Florida, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) (“Jupiter” or the “Company”), a clinical-stage pharmaceutical…

11 months ago